Health care experts urge increased awareness of obstructive sleep apnea (OSA) among people with cardiovascular disease or risk factors such as high blood pressure, according to a new study. OSA occurs ...

Annual medical checkups typically cover the basics: diet, exercise and mental state. Surprisingly, many primary care providers fail to ask about one of the fundamental contributors to well-being: ...

Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, ...

Positional therapy can be a long-lasting and effective treatment for patients with positional obstructive sleep apnea (OSA), according to research presented at the 2026 ATS International Conference.

Snoring is more than just a nighttime nuisance—it can signal underlying health issues, including sleep apnea. Understanding ...

Sleep breathing disorders (SBDs)—including obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation syndromes—represent a major yet under-recognised contributor to global ...

Eli Lilly and Company , the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and ...

You can typically stop drooling in your sleep by sleeping on your back and clearing your nasal passages. Treating underlying causes like allergies and sleep apnea can prevent drooling. Drooling in ...

In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving =30% weight loss, a level long ...

Staying awake for 24 hours can cause symptoms like anxiety, impaired judgment, and irritability. Long-term sleep deprivation increases your risk of conditions like heart disease and depression. Having ...